Multicenter analytical evaluation of an automated 185-190 immunoassay for total plasma homocysteine

Annals of Clinical and Laboratory Science

Volumn 30, Issue 2, 2000, Pages 185-190

  Wu, Alan H B ^a   Holtman, Verena ^a   Apple, Fred S ^b   Ricchiuti, Vincent ^b   DiBello, Patricia M ^c   Jacobsen, Donald ^c  

^a HARTFORD HOSPITAL   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cardiovascular disease; Fluorescence polarization immunoassay; Plasma homocysteine

Indexed keywords

DITHIOTHREITOL; HOMOCYSTEINE;

CORONARY ARTERY DISEASE; FLUORESCENCE POLARIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; PLASMA; PRIORITY JOURNAL; REFERENCE VALUE; REVIEW; SERUM;

CHEMISTRY, CLINICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORONARY DISEASE; EVALUATION STUDIES; HOMOCYSTEINE; HUMANS; IMMUNOASSAY; REFERENCE VALUES; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 0034008358     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease-probably benefits of increasing folic acid intakes. J Am Med Assoc 1995; 274:1049-1057.
2. Refsum H, Ueland P, Nygård O, Vollset SE. Homocysteine and cardiovascular disease. Ann Rev Med 1998;49:31-62.
3. Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996; 27:517-527.
4. Coull BM, Malinow MR, Beamer H, Sexton G, Nordt F, de Garmo P. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke 1990;21:572-576.
5. Taylor LM Jr, Moneta GL, Sexton GJ, Schuff RA, Porter JM, and the Homocysteine and Progression of Atherosclerosis Study Investigators. Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease. J Vase Surg 1999;29:8-19.
6. D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood 1997;90:1-11.
7. Bostom AG, Lathrop L. Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 1997;52:10-20.
8. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J Am Med Assoc 1993;270:2693-2698.
9. Nygård O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland M, Kvale G. Total plasma homocysteine and cardiovascular risk profile-the Hordaland homocysteine study. J Am Med Assoc 1995; 274;1526-1533.
10. Green R, Jacobsen DW. Clinical implications of hyperhomocysteinemia. In: Folate in Health and Disease (Bailey LB, ed), Marcell Dekker, Inc, New York, 1995; pp 75-122.
11. Nygård O, Refsum H, Ueland PM, Vollset SE. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland homocysteine study. Am J Clin Nutr 1998;67:263-270.
12. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: Methods and clinical applications. Clin Chem 1993;39:1764-1779.
13. Stabler SP, Marcel PD, Podell ER, Allen RH. Quantitation of total homocysteine, total cysteine, and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry. Anal Biochem 1997;162:185-196.
14. Malinow MR, Kang S-S, Taylor LM, Wong PW, Coull B, Inahara T, Mukerjee D, Sexton G, Upson B. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 1989; 79:1180-1188.
15. Refsum H, Ueland PM, Svardal AM. Fully automated fluorescence assay for determining total homocystine in plasma. Clin Chem 1989;35:1921-1927.
16. Vester B, Rasmussen K. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem 1991;29:549-554.
17. Jacobsen DW, Gatautis VJ, Green R, Robinson K, Savon SR, Seek M, Ji J, Otto JM, Taylor LM Jr. Rapid HPLC determination of total homocystine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate levels in normal subjects. Clin Chem 1994;40:873-881.
18. Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem 1995;41:991-994.
19. Frantzen F, Faaren AL, Alfheim I, Nordhei AK. Enzyme conversion immunoassay for determining total homocystine in plasma or serum. Clin Chem 1998; 44:311-316.
20. Alfheim I, Auerbekk A, Holets-McCormack S, Shih J. Development of an assay for homocysteine on an automated immunoassay analyzer (Abstract). Clin Chem 1998;44(suppl):A170.
21. Dudman N, Guo X, Crooks R, Xie L, Silberberg J. Assay of plasma homocysteine: light sensitivity of the fluorescent 7-benzo-2-oxa-1,3-diazole-4-sulfonic acid derivative, and use of appropriate calibrators. Clin Chem 1996;42:2028-2032.
22. Pietzsch J, Pixa A. Determination of total homocysteine. Clin Chem 1998;44:1781-1782.
23. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764-1769.
24. Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet, and cardiovascular diseases. A statement for healthcare professions from the Nutrition Committee, American Heart Association. Circulation 1999;99:178-182.